The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Airway Stent Placement

Endobronchial stent insertion for central airway obstruction

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Göğüs Hastalıkları department. Book Appointment →

What is Airway Stent Placement?

Airway stents are tubular endoluminal devices used to maintain patency of the central airways (trachea and main bronchi) compromised by intrinsic obstruction (tumor, granulation tissue, post-intubation stenosis) or extrinsic compression (mediastinal mass, lymphadenopathy, vascular ring). Available stent types include silicone (Dumon, Polyflex) requiring rigid bronchoscopy for placement and easy repositioning, self-expanding metallic stents (covered or uncovered nitinol, stainless steel) deployed through flexible bronchoscopy for distal lesions, and hybrid stents combining metal scaffolding with silicone covering for tumor in-growth resistance.

Indications include malignant airway obstruction with imminent or established respiratory compromise (advanced lung cancer, esophageal cancer with airway invasion, mediastinal lymphoma, metastatic disease), benign tracheal stenosis from prolonged intubation, post-tracheostomy stenosis, anastomotic complications after lung transplant or sleeve resection, tracheomalacia, and tracheoesophageal fistula. Pre-procedure imaging with CT and bronchoscopic mapping defines lesion length, location, and degree of stenosis, guiding stent selection. Procedures are performed under general anesthesia, often combined with debulking via mechanical removal, electrocautery, argon plasma coagulation, laser, cryotherapy, or photodynamic therapy.

Outcomes depend on indication: malignant obstruction shows immediate symptom relief in 85-95%, with median patency 3-6 months matching survival; benign stenosis has more variable durability with risk of granulation tissue formation requiring repeat interventions. Complications include migration (5-15%), mucus plugging, granulation overgrowth at stent margins, stent fracture, and rare perforation. Routine surveillance bronchoscopy every 3-6 months allows early intervention for these complications. Adjunctive therapies include nebulized saline, mucolytics, and treatment of underlying disease. Patient selection by a multidisciplinary team including interventional pulmonology, thoracic surgery, oncology, and anesthesiology optimizes outcomes.

Symptoms

Severe dyspnea and stridor from airway narrowing
Wheezing localized to a specific area
Hemoptysis from tumor or granulation
Cough with progressive worsening
Hypoxemia and respiratory distress
Failed weaning from mechanical ventilation
Imaging evidence of tracheal or bronchial obstruction

Risk Factors

Advanced lung cancer with airway invasion
Esophageal cancer or mediastinal mass
Prolonged intubation and post-extubation stenosis
Post-tracheostomy stenosis
Lung transplant anastomotic complications
Tracheomalacia or relapsing polychondritis
Tracheoesophageal fistula

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Progressive dyspnea with audible stridor
  • Hemoptysis with known thoracic malignancy
  • Failed extubation due to airway narrowing
  • Imaging showing significant central airway compromise
  • Severe respiratory distress requiring urgent palliation
  • Recurrent symptoms after prior stent placement
  • Suspected stent migration or obstruction

Treatment Methods

01
Pre-procedure CT and bronchoscopic mapping
02
Rigid or flexible bronchoscopy under general anesthesia
03
Tumor debulking with electrocautery, argon plasma, or laser
04
Silicone or self-expanding metallic stent deployment
05
Hybrid stents for malignant disease with in-growth risk
06
Routine surveillance bronchoscopy every 3-6 months
07
Multidisciplinary management with oncology and surgery

Which Department to Visit?

You can visit our Göğüs Hastalıkları department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Göğüs Hastalıkları Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Asthma

Göğüs Hastalıkları

Asthma is characterized by wheezing, coughing and shortness of breath attacks; with proper treatment it can be kept under control.

COPD (Chronic Obstructive Pulmonary Disease)

Göğüs Hastalıkları

COPD is an irreversible lung disease characterized by shortness of breath and chronic cough; quitting smoking slows its progression.

Pneumonia

Göğüs Hastalıkları

Pneumonia presents with high fever, cough and shortness of breath; the vast majority recover with appropriate antibiotic treatment.

Tuberculosis (TB)

Göğüs Hastalıkları

Tuberculosis presents with weeks-to-months of cough, fever, and night sweats; early diagnosis and treatment lead to full recovery.

Pleural Effusion

Göğüs Hastalıkları

Pleural effusion is the accumulation of excess fluid in the pleural space, resulting from imbalances in fluid production and removal, and represents a manifestation of diverse cardiopulmonary, infectious, and malignant disorders.

Pneumothorax

Göğüs Hastalıkları

Pneumothorax is the presence of air in the pleural space resulting in partial or complete lung collapse, classified as spontaneous (primary/secondary), traumatic, or iatrogenic, with tension pneumothorax representing a life-threatening emergency.

Bronchitis (Acute and Chronic)

Göğüs Hastalıkları

Acute bronchitis is mostly viral and resolves spontaneously, while chronic bronchitis is a smoking-related component of COPD.

Bronchiectasis

Göğüs Hastalıkları

Bronchiectasis is a chronic respiratory disease characterized by permanent, abnormal dilation of bronchi with associated destruction of muscular and elastic components of airway walls, resulting in impaired mucociliary clearance and recurrent infection.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.